Zdravlje AD commercial division is fully capable and organized to replace multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE and wider, when multinational chooses not to enter, or to exit some market.
With 70 years of experience and market presence, Zdravlje AD is already an established partner for ethical pharmaceuticals distribution and promotion in CEE.
Our management team is combining experience from biopharma, OTC and supplement market leaders, creating most flexible environment for successful preparation, launch and market presence development of products from various market groups and therapeutic areas.
We are providing multi-market ONE Point of contact for our partners in regulatory, Market Access, Marketing&Promotion, logistics and forecasting.
Zdravlje has affiliates in Poland, Romania, Bulgaria, Croatia, Bosnia, Montenegro, North Macedonia, and dedicated sales force in other markets with sub-distributor. Our portfolio is highly differentiated, from biologics and specialty pharma, to generics, OTC and food supplements. Our team has expertise for market research and evaluating opportunities for new business, so, when opportunity arise, we have the ability to act quickly and efficiently.
We are selected partners of some of the largest companies, such as Celltrion Healthcare (Poland, Slovenia, Serbia, Bosnia, Montenegro, North Macedonia, Albania) for Regkirona (MaB used in Covid19 treatment), Medicair for Vioplex-T and several other dermatology products, Sanovel (EU and Non-EU markets), Farmatek (Non-EU Balkans), Pharmactive (Eu and Non-EU markets) as well as many others.
Please contact us on corporate@zdravlje.co.rs so we can organize a meeting and discuss further our cooperation.